Paramyxovirus F1 protein has two fusion peptides: Implications for the mechanism of membrane fusion

Journal of Molecular Biology

Volumn 296, Issue 5, 2000, Pages 1353-1365

  Peisajovich, Sergio Gerardo ^a   Samuel, Orit ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Fluorescence; Fusion peptide; Membrane fusion; Paramyxoviridae; Viral entry

Indexed keywords

HYBRID PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN F1;

AMINO TERMINAL SEQUENCE; ARTICLE; ENERGY TRANSFER; GENE FUSION; HYDROPHOBICITY; MEMBRANE FUSION; NONHUMAN; PARAMYXOVIRUS; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

EID: 0034628898     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.3543     Document Type: Article

References (82)

1. Structural basis for paramyxovirus-mediated membrane fusion
2. Membrane-induced step in the activation of Sendai virus fusion protein
3. Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion
4. Architecture of the influenza hemagglutinin membrane fusion site
5. Melittin binding to mixed phosphatidylglycerol/phosphatidylcholine membranes
6. Sequence determination of the Sendai virus fusion protein gene
7. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events
8. Identification of the fusion peptide of primate immunodeficiency viruses
9. Differentiation of lipid-associating helices by use of three- dimensional molecular hydrophobicity potential calculations
10. Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N terminus of viral fusion proteins
11. Structure of influenza haemagglutinin at the pH of membrane fusion
12. Core structure of gp41 from the HIV envelope glycoprotein
13. Determination of the equilibrium micelle-inserting position of the fusion peptide of gp41 of human immunodeficiency virus type 1 at amino acid resolution by exchange broadening of amide proton resonances
14. Parainfluenza Viruses
15. Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses
16. Paramyxovirus fusion protein: Characterization of the core trimer, a rod-shaped complex with helices in anti-parallel orientation
17. Lipid polymorphism and protein-lipid interactions
18. The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion
19. Retrovirus envelope domain at 1.7 angstrom resolution
20. Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity
21. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity
22. Surface density determination in membranes by fluorescence energy transfer
23. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus
24. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses
25. Structural and functional characterization of the alpha 5 segment of Bacillus thuringiensis delta-endotoxin
26. Purification of the fusion protein of Sendal virus: Analysis of the NH2-terminal sequence generated during precursor activation
27. Studies on the mechanism of membrane fusion: Site-specific mutagenesis of the hemagglutinin of influenza virus
28. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion
29. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus
30. Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion
31. Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the 'fusion peptide'
32. Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein
33. Entry mechanisms of enveloped viruses. Implications for fusion of intracellular membranes
34. Trypsin action on the growth of sendai virus in tissue culture cells
35. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion
36. Complete sequence of the Rous sarcoma virus env gene: Identification of structural and functional regions of its product
37. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study
38. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins
39. A mechanism of protein-mediated fusion: Coupling between refolding of the influenza hemagglutinin and lipid rearrangements
40. Paramyxoviridae: The viruses and their replication
41. Effect of amphipathic peptides with different alpha-helical contents on liposome-fusion
42. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein
43. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides
44. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9 Å resolution
45. Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: An infrared spectroscopy study
46. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer
47. Synthesis of the antibacterial peptide cecropin A (1-33)
48. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: Different structural requirements for fusion and leakage
49. Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution
50. Membrane fusion induced by the HIV type 1 fusion peptide: Modulation by factors affecting glycoprotein 41 activity and potential anti-HIV compounds
51. 11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes
52. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation
53. Phospholipid interactions of synthetic peptides representing the N terminus of H1V gp41
54. Synthesis, location, and lateral mobility of fluorescently labeled ubiquinone 10 in mitochondrial and artificial membranes
55. Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers
56. Aggregation and organization of pardaxin in phospholipid membranes. A fluorescence energy transfer study
57. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes
58. pH- and ionic strength-dependent fusion of phospholipid vesicles induced by pardaxin analogues or by mixtures of charge-reversed peptides
59. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses
60. Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus
61. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses
62. Channel formation properties of synthetic pardaxin and analogues
63. pH-dependent pore formation properties of pardaxin analogues
64. Membrane fusion. Anchors aweigh
65. Influenza Virus fusion: From models toward a mechanism
66. Protein-mediated membrane fusion
67. Use of resonance energy transfer to monitor membrane fusion
68. Influenza hemagglutinin assumes a tilted conformation during membrane fusion as determined by attenuated total reflection FTIR spectroscopy
69. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells
70. Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein
71. Atomic structure of the ectodomain from HIV-1 gp41
72. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain
73. Membrane fusion by peptide analogues of influenza virus haemagglutinin
74. Membrane fusion proteins of enveloped animal viruses
75. Viral and cellular membrane fusion proteins
76. A fusion-defective mutant of the vesicular stomatitis virus glycoprotein
77. Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution
78. The crystal structure of the SIV gp41 ectodomain at 1.47 Å resolution
79. Effects of the 'fusion peptide' from measles virus on the structure of N-methyl dioleoylphosphatidylethanolamine membranes and their fusion with Sendai virus
80. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions
81. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes
82. Mechanisms of membrane fusion